Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Recurrence × lenvatinib × Clear all

Phase

Status

Completed 4 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 38 Liver Neoplasms 4 Cholangiocarcinoma 3 Advanced Biliary Tract Cancer 3 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Biliary Tract Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer Metastatic 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Potentially Resectable Locally Advanced Malignant Tumors of Biliary System 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Cirrhosis 1 Klatskin Tumor 1 Hepatoblastoma 1 HER2-negative Advanced Gastric Cancer 1 Gastric Cancer Metastatic to Liver 1 Gallbladder Neoplasms 1 First-line Treatment 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Tumor 1 Advanced Primary Liver Cancer 1

Interventions

Cyclophosphamide 16 fludarabine 12 Cisplatin 11 Rituximab 9 Dexamethasone 9 Gemcitabine 8 Cytarabine 7 fludarabine phosphate 6 Paclitaxel 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Lenalidomide 6 Decitabine 6 Radiotherapy 5 Etoposide 5 Carboplatin 5 Bendamustine Hydrochloride 5 camrelizumab 4 apatinib 4 Valproic Acid 4 Thalidomide 4 Procarbazine 4 Oxaliplatin 4 Injections 4 Bortezomib 4 Antilymphocyte Serum 4 tislelizumab 3 pomalidomide 3 Vinorelbine 3 Vinblastine 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05910970 2024-01-23

PREVENT-2

Guangxi Medical University

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡